Pages that link to "Q34215767"
Jump to navigation
Jump to search
The following pages link to GHB: a new and novel drug of abuse (Q34215767):
Displaying 50 items.
- Gamma-hydroxybutyrate (GHB) for treatment of alcohol withdrawal and prevention of relapses (Q24240050) (← links)
- Inwardly rectifying potassium channels: their structure, function, and physiological roles (Q24296441) (← links)
- Behavioral analyses of GHB: receptor mechanisms (Q24645147) (← links)
- Safety overview of postmarketing and clinical experience of sodium oxybate (Xyrem): abuse, misuse, dependence, and diversion (Q24653625) (← links)
- Unravelling the brain targets of gamma-hydroxybutyric acid (Q24670043) (← links)
- Biology and therapy of fibromyalgia. New therapies in fibromyalgia (Q24684137) (← links)
- Substance abuse and pharmacy practice: what the community pharmacist needs to know about drug abuse and dependence (Q24805157) (← links)
- Focal neurometabolic alterations in mice deficient for succinate semialdehyde dehydrogenase (Q28204777) (← links)
- Succinic Semialdehyde Dehydrogenase: Biochemical–Molecular–Clinical Disease Mechanisms, Redox Regulation, and Functional Significance (Q28743137) (← links)
- Club drugs: old medicines as new party drugs (Q30342951) (← links)
- Recent advances in the development of treatments for alcohol and cocaine dependence: focus on topiramate and other modulators of GABA or glutamate function (Q30438149) (← links)
- Rave culture and drug rape (Q30540201) (← links)
- A Qualitative Descriptive Study of Perceived Sexual Effects of Club Drug Use in Gay and Bisexual Men. (Q33677137) (← links)
- Management of Gamma-Butyrolactone Dependence with Assisted Self-Administration of GBL. (Q33904143) (← links)
- Effects of gamma-hydroxybutyric acid on spatial learning and memory in adolescent and adult female rats (Q34080663) (← links)
- The involvement of gamma-hydroxybutyrate in reported sexual assaults: a systematic review (Q34116663) (← links)
- Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse. (Q34165511) (← links)
- An overview of gamma‐hydroxybutyric acid: pharmacodynamics, pharmacokinetics, toxic effects, addiction, analytical methods, and interpretation of results (Q34168958) (← links)
- Sodium oxybate for the treatment of fibromyalgia (Q34193082) (← links)
- Acute toxic effects of club drugs (Q34370377) (← links)
- Sodium oxybate: a review of its use in alcohol withdrawal syndrome and in the maintenance of abstinence in alcohol dependence (Q34389840) (← links)
- Recognition and management of complications of new recreational drug use. (Q34558621) (← links)
- Club drugs as causal risk factors for HIV acquisition among men who have sex with men: a review (Q34569081) (← links)
- Methamphetamine and Viagra use: relationship to sexual risk behaviors (Q34619361) (← links)
- Intravenous self-administration of γ-hydroxybutyrate (GHB) in baboons (Q34630587) (← links)
- The effects and consequences of selected club drugs (Q34830911) (← links)
- Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths (Q35090740) (← links)
- Guidelines and methodological reviews concerning drug abuse liability assessment (Q35132177) (← links)
- GHB pharmacology and toxicology: acute intoxication, concentrations in blood and urine in forensic cases and treatment of the withdrawal syndrome (Q35710620) (← links)
- Gamma hydroxy butyrate abuse and dependency (Q36116159) (← links)
- Party drugs: properties, prevalence, patterns, and problems (Q36209983) (← links)
- Recent trends in the use of "club drugs": an Australian review (Q36209990) (← links)
- Suppression by γ-Hydroxybutyric Acid of "Alcohol Deprivation Effect" in Rats: Preclinical Evidence of its anti-Relapse Properties (Q36370079) (← links)
- Differential effects of 3,4-methylenedioxypyrovalerone (MDPV) and 4-methylmethcathinone (mephedrone) in rats trained to discriminate MDMA or a d-amphetamine MDMA mixture (Q36510321) (← links)
- Psychological drivers in doping: the life-cycle model of performance enhancement (Q36562842) (← links)
- Gamma-hydroxybutyrate--a drug of abuse (Q36566720) (← links)
- Regulation of glucagon secretion in normal and diabetic human islets by γ-hydroxybutyrate and glycine (Q36596183) (← links)
- A qualitative analysis of GHB use among gay men: Reasons for use despite potential adverse outcomes. (Q36726194) (← links)
- Physical dependence on gamma-hydroxybutrate (GHB) prodrug 1,4-butanediol (1,4-BD): time course and severity of withdrawal in baboons. (Q37033882) (← links)
- Hallucinogenic plants of abuse (Q37123493) (← links)
- Gamma-hydroxybutyric acid in male and female cynomolgus monkeys trained to discriminate 1.0 or 2.0 g/kg ethanol (Q37246216) (← links)
- Illicit gamma-hydroxybutyrate (GHB) and pharmaceutical sodium oxybate (Xyrem): differences in characteristics and misuse (Q37268694) (← links)
- Improving GHB withdrawal with baclofen: study protocol for a feasibility study for a randomised controlled trial (Q37291754) (← links)
- Gamma hydroxybutyric acid (GHB) for the treatment of alcohol dependence: a review (Q37541691) (← links)
- Emerging treatments for narcolepsy and its related disorders (Q37694570) (← links)
- Acute toxicity and withdrawal syndromes related to γ-hydroxybutyrate (GHB) and its analogues γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD). (Q37872702) (← links)
- Reconsidering GHB: orphan drug or new model antidepressant? (Q37934335) (← links)
- Alternative drugs of abuse (Q38103475) (← links)
- Sodium oxybate in the treatment of alcohol dependence: from the alcohol withdrawal syndrome to the alcohol relapse prevention (Q38166827) (← links)
- Gamma-hydroxybutyrate (GHB): a scoping review of pharmacology, toxicology, motives for use, and user groups (Q38232868) (← links)